Histamine antagonists promote cancer immunosurveillance
Recently, a cellular mini-immune system comprising infinitely expandable dendritic cells and T cells led to the discovery that histamine receptor H1 antagonists act on T cells to stimulate their proliferation and polarization toward a Th1/Tc1 phenotype and to increase their anticancer activity in th...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2023-12-01
|
| Series: | OncoImmunology |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/2162402X.2023.2242211 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850059970278588416 |
|---|---|
| author | Peng Liu Guido Kroemer Oliver Kepp |
| author_facet | Peng Liu Guido Kroemer Oliver Kepp |
| author_sort | Peng Liu |
| collection | DOAJ |
| description | Recently, a cellular mini-immune system comprising infinitely expandable dendritic cells and T cells led to the discovery that histamine receptor H1 antagonists act on T cells to stimulate their proliferation and polarization toward a Th1/Tc1 phenotype and to increase their anticancer activity in the context of immunochemotherapy. |
| format | Article |
| id | doaj-art-268536b220294c74a18ab889a5dc5f13 |
| institution | DOAJ |
| issn | 2162-402X |
| language | English |
| publishDate | 2023-12-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | OncoImmunology |
| spelling | doaj-art-268536b220294c74a18ab889a5dc5f132025-08-20T02:50:44ZengTaylor & Francis GroupOncoImmunology2162-402X2023-12-0112110.1080/2162402X.2023.2242211Histamine antagonists promote cancer immunosurveillancePeng Liu0Guido Kroemer1Oliver Kepp2Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Center, Université Paris Saclay, Villejuif, FranceMetabolomics and Cell Biology Platforms, Gustave Roussy Cancer Center, Université Paris Saclay, Villejuif, FranceMetabolomics and Cell Biology Platforms, Gustave Roussy Cancer Center, Université Paris Saclay, Villejuif, FranceRecently, a cellular mini-immune system comprising infinitely expandable dendritic cells and T cells led to the discovery that histamine receptor H1 antagonists act on T cells to stimulate their proliferation and polarization toward a Th1/Tc1 phenotype and to increase their anticancer activity in the context of immunochemotherapy.https://www.tandfonline.com/doi/10.1080/2162402X.2023.2242211cancercell deathimmunotherapy |
| spellingShingle | Peng Liu Guido Kroemer Oliver Kepp Histamine antagonists promote cancer immunosurveillance OncoImmunology cancer cell death immunotherapy |
| title | Histamine antagonists promote cancer immunosurveillance |
| title_full | Histamine antagonists promote cancer immunosurveillance |
| title_fullStr | Histamine antagonists promote cancer immunosurveillance |
| title_full_unstemmed | Histamine antagonists promote cancer immunosurveillance |
| title_short | Histamine antagonists promote cancer immunosurveillance |
| title_sort | histamine antagonists promote cancer immunosurveillance |
| topic | cancer cell death immunotherapy |
| url | https://www.tandfonline.com/doi/10.1080/2162402X.2023.2242211 |
| work_keys_str_mv | AT pengliu histamineantagonistspromotecancerimmunosurveillance AT guidokroemer histamineantagonistspromotecancerimmunosurveillance AT oliverkepp histamineantagonistspromotecancerimmunosurveillance |